Ovid Therapeutics OVID
NASDAQ OVID
$2.43 +0.00 (+0.21%)
As of: Oct 2, 2026 · 10:10 AM EDT

Ovid Therapeutics (OVID) Non Operating Income (2016 - 2020)

Updated

Ovid Therapeutics' Non Operating Income came in at $590,491 for Q2 2020, up 122.8% from $264,999 a year earlier and up 123.4% from the prior quarter.

Analysis

Ovid Therapeutics (OVID) Non Operating Income (2016 - 2020) Analysis & Trends

Over the trailing twelve months to Jun 30, 2020, Ovid Therapeutics reported Non Operating Income of $1.28 million, up 35.5% year-over-year; for FY2019, it was $948,224, down 0.4% from FY2018.

  • Non Operating Income carries a four-year compound annual growth rate of 136.6% (FY2015 to FY2019).
  • Going back by year, Non Operating Income was $952,073 in FY2018 (+372.5%), $201,509 in FY2017 (+66.8%), $120,822 in FY2016 (+299.0%) and $30,281 in FY2015.
  • The Q2 2020 figure represents the highest quarterly Non Operating Income in data going back to Q1 2016.
  • Year-over-year, Non Operating Income has increased for three consecutive quarters, with growth averaging 73.8% over the last eight quarters.
  • The fastest year-over-year change in Non Operating Income over five years came in Q1 2018 (growth of 973.9%), and the weakest in Q3 2019 (a decline of 38.8%).
  • Business Quant data shows OVID's Non Operating Income at $264,296 (Q1 2020), $299,000 (Q4 2019) and $131,000 (Q3 2019) in the three quarters before Q2 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -73.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 387.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Ovid Therapeutics 460.04 Mn 92.06 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 590,491.00
Mar 31, 2020 264,296.00
Dec 31, 2019 299,000.00
Sep 30, 2019 131,000.00
Jun 30, 2019 264,999.00
Mar 31, 2019 253,340.00
Dec 31, 2018 216,000.00
Sep 30, 2018 214,000.00
Jun 30, 2018 275,000.00
Mar 31, 2018 247,000.00
Dec 31, 2017 88,000.00
Sep 30, 2017 51,000.00
Jun 30, 2017 40,000.00
Mar 31, 2017 23,000.00
Dec 31, 2016 27,000.00
Sep 30, 2016 30,000.00
Jun 30, 2016 31,000.00
Mar 31, 2016 32,000.00
API Access

Ovid Therapeutics Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=OVID&period=max&api_key=YOUR_API_KEY